TY - JOUR
T1 - Combined PARP1-targeted nuclear contrast and reflectance contrast enhances confocal microscopic detection of basal cell carcinoma
AU - Sahu, Aditi
AU - Cordero, Jose
AU - Wu, Xiancheng
AU - Kossatz, Susanne
AU - Harris, Ucalene
AU - Franca, Paula Demetrio Desouza
AU - Kurtansky, Nicholas R.
AU - Everett, Niasia
AU - Dusza, Stephen
AU - Monnier, Jilliana
AU - Kumar, Piyush
AU - Fox, Christi
AU - Brand, Christian
AU - Roberts, Sheryl
AU - Kose, Kivanc
AU - Phillips, William
AU - Lee, Erica
AU - Chen, Chih Shan Jason
AU - Rossi, Anthony
AU - Nehal, Kishwer
AU - Pulitzer, Melissa
AU - Longo, Caterina
AU - Halpern, Allan
AU - Reiner, Thomas
AU - Rajadhyaksha, Milind
AU - Jain, Manu
N1 - Publisher Copyright:
© 2022 Society of Nuclear Medicine Inc.. All rights reserved.
PY - 2022/6/1
Y1 - 2022/6/1
N2 - Reflectance confocal microscopy (RCM) with endogenous backscattered contrast can noninvasively image basal cell carcinomas (BCCs) in skin. However, BCCs present with high nuclear density and the relatively weak backscattering from nuclei impose a fundamental limit on contrast, detectability, and diagnostic accuracy. We investigated PARPi-FL, an exogenous nuclear poly (ADP-ribose) polymerase (PARP1)-targeted fluorescent contrast agent and fluorescence confocal microscopy (FCM) towards improving BCC diagnosis. Methods: We tested PARP1 expression in 95 BCC tissues using immunohistochemistry, followed by PARPi-FL staining in 32 fresh surgical BCC specimens. Diagnostic accuracy of PARPi-FL contrast was evaluated in 83 surgical specimens. Optimal parameters for trans-epidermal permeability of PARPi-FL through intact skin was tested ex vivo on 5 human skin specimens and in vivo in 3 adult Yorkshire pigs. Results: We found significantly higher PARP1 expression and PARPi-FL binding in BCCs, as compared to normal skin structures. Blinded reading of RCM-and-FCM images by two experts demonstrated a higher diagnostic accuracy for BCCs with combined fluorescence and reflectance contrast, as compared to RCM-alone. Optimal parameters (time and concentration) for PARPi-FL trans-epidermal permeation through intact skin were successfully determined. Conclusion: Combined fluorescence and reflectance contrast may improve noninvasive BCC diagnosis with confocal microscopy.
AB - Reflectance confocal microscopy (RCM) with endogenous backscattered contrast can noninvasively image basal cell carcinomas (BCCs) in skin. However, BCCs present with high nuclear density and the relatively weak backscattering from nuclei impose a fundamental limit on contrast, detectability, and diagnostic accuracy. We investigated PARPi-FL, an exogenous nuclear poly (ADP-ribose) polymerase (PARP1)-targeted fluorescent contrast agent and fluorescence confocal microscopy (FCM) towards improving BCC diagnosis. Methods: We tested PARP1 expression in 95 BCC tissues using immunohistochemistry, followed by PARPi-FL staining in 32 fresh surgical BCC specimens. Diagnostic accuracy of PARPi-FL contrast was evaluated in 83 surgical specimens. Optimal parameters for trans-epidermal permeability of PARPi-FL through intact skin was tested ex vivo on 5 human skin specimens and in vivo in 3 adult Yorkshire pigs. Results: We found significantly higher PARP1 expression and PARPi-FL binding in BCCs, as compared to normal skin structures. Blinded reading of RCM-and-FCM images by two experts demonstrated a higher diagnostic accuracy for BCCs with combined fluorescence and reflectance contrast, as compared to RCM-alone. Optimal parameters (time and concentration) for PARPi-FL trans-epidermal permeation through intact skin were successfully determined. Conclusion: Combined fluorescence and reflectance contrast may improve noninvasive BCC diagnosis with confocal microscopy.
KW - basal cell carcinoma
KW - cancer diagnosis
KW - fluorescence confocal microscopy
KW - in vivo
KW - nuclear contrast
KW - reflectance confocal microscopy
UR - http://www.scopus.com/inward/record.url?scp=85131270297&partnerID=8YFLogxK
U2 - 10.2967/jnumed.121.262600
DO - 10.2967/jnumed.121.262600
M3 - Article
C2 - 34649941
AN - SCOPUS:85131270297
SN - 0161-5505
VL - 63
JO - Journal of Nuclear Medicine
JF - Journal of Nuclear Medicine
IS - 6
ER -